Access cutting-edge lung cancer treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Orlando at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
Multicenter, randomized, controlled, open-label, Phase 3 study designed to demonstrate that neladalkib (NVL-655) is superior to alectinib in prolonging progression-free survival (PFS) in patients with treatment-naïve, Anaplastic Lymphoma Kinase (ALK) positive, advanced Non-Small Cell Lung Cancer (NSCLC).
Sponsor: Nuvalent Inc.
Check if you qualify for this lung cancer clinical trial in Orlando, FL
If you're searching for lung cancer treatment options in Orlando, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.